Connect to other sites within the UBM Medica Network
Could Gene Assay Help Guide Stage II Colon Cancer Treatment?
In this interview we discuss the GeneFx Colon test (or the ColDx assay), which can helpful identify patients with low- or high-risk stage II colon cancer.
New Consensus Guidelines on DCIS Establish Ideal Surgical Margins
In this interview we discuss new consensus guidelines from ASCO, SSO, and ASTRO that establish 2 mm surgical margins for treating DCIS patients.
Finding the Mechanisms of Immunotherapy Resistance
In this interview we discuss a recent study that identified genetic mechanisms of immunoresistance to treatment with anti-PD-1 antibodies.
Latest Immunotherapy Research in Treating Colorectal Cancer
In this interview we discuss the CheckMate 142 trial, which looked at nivolumab and ipilimumab for the treatment of metastatic colorectal cancer.
Follow-Up Care and Screening for Cancer Survivors
In this interview we discuss follow-up care and screening for second primary cancers in cancer survivors.
Late Effects of Radiotherapy in Gynecologic Cancers
In this interview we discuss the management of late effects from radiotherapy in patients treated for gynecologic cancers.
Requirements for Effective Lung Screening Programs Coming Into Focus
In this interview we discuss the requirements for the effective implementation of a lung cancer screening program.
Treating Triple-Negative Breast Cancer
This slide deck covers the treatment of triple-negative breast cancer, a heterogeneous disease made up of numerous subtypes, and includes clinical variables that can help with prognosis and guide in treatment choice.
By clicking Accept, you agree to become a member of the UBM Medica Community.